Gene · 57142
Papers2,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endoplasmic reticulum membrane remodeling by targeting reticulon-4 induces pyroptosis to facilitate antitumor immune. | Protein Cell | 2025 | 39252612 | PubTator, text mining | PubMed |
| Modulation of the Nogo signaling pathway to overcome amyloid-β-mediated neurite inhibition in human pluripotent stem cell-derived neurites. | Neural Regen Res | 2025 | 39105379 | PubTator, text mining | PubMed |
| Nogo-B Silencing Expedites the Senescence of Platelet-Derived Growth Factor-BB-Induced Human Hepatic Stellate Cells Via Autophagy. | Mol Biotechnol | 2025 | 38727882 | PubTator, text mining | PubMed |
| Unraveling the causal relationship and potential mechanisms between osteoarthritis and breast cancer: insights from mendelian randomization and bioinformatics analysis. | Discov Oncol | 2024 | 39692948 | PubTator, text mining | PubMed |
| Unraveling of Phosphotyrosine Signaling Complexes Associated with T Cell Exhaustion Using Multiplex Co-Fractionation/Mass Spectrometry. | Anal Chem | 2024 | 39661755 | PubTator, text mining | PubMed |
| Gender-modulated influence of BDNF concentration and Val66Met polymorphism on cognitive outcomes in chronic limb ischemia patients. | Front Endocrinol (Lausanne) | 2024 | 39619329 | PubTator, text mining | PubMed |
| Correction: An unexpected role of Nogo-A as regulator of tooth enamel formation. | Int J Oral Sci | 2024 | 39511159 | PubTator, text mining | PubMed |
| Increased levels of versican and insulin-like growth factor 1 in peritumoral mammary adipose tissue are related to aggressiveness in estrogen receptor-positive breast cancer. | Mol Med | 2024 | 39501160 | PubTator, text mining | PubMed |
| Genetic Analysis of Neurite Outgrowth Inhibitor-Associated Genes in Parkinson's Disease: A Cross-Sectional Cohort Study. | CNS Neurosci Ther | 2024 | 39354865 | PubTator, text mining | PubMed |
| Corrigendum to "Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment" [Int. Immunopharmacol. 140 (2024) 112763]. | Int Immunopharmacol | 2024 | 39289042 | PubTator, text mining | PubMed |
| Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia. | Cell Rep | 2024 | 39235944 | PubTator, text mining | PubMed |
| Nogo Receptor Antagonist LOTUS Promotes Neurite Outgrowth through Its Interaction with Teneurin-4. | Cells | 2024 | 39195260 | PubTator, text mining | PubMed |
| Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism. | Genes Nutr | 2024 | 39182019 | PubTator, text mining | PubMed |
| Intestinal Nogo-B reduces GLP1 levels by binding to proglucagon on the endoplasmic reticulum to inhibit PCSK1 cleavage. | Nat Commun | 2024 | 39122737 | PubTator, text mining | PubMed |
| Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population. | Front Aging Neurosci | 2024 | 39109268 | PubTator, text mining | PubMed |
| Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment. | Int Immunopharmacol | 2024 | 39083925 | PubTator, text mining | PubMed |
| Introduction to the Special Issue Dedicated to Extracellular Vesicles and Nanoparticles, Part 1. | Int J Mol Sci | 2024 | 39063047 | PubTator, text mining | PubMed |
| Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction. | J Cardiovasc Transl Res | 2024 | 39009944 | PubTator, text mining | PubMed |
| Exploring Hypertrophic Cardiomyopathy Biomarkers through Integrated Bioinformatics Analysis: Uncovering Novel Diagnostic Candidates. | Cardiol Res Pract | 2024 | 38994496 | PubTator, text mining | PubMed |
| Endoplasmic reticulum morphology regulation by RTN4 modulates neuronal regeneration by curbing luminal transport. | Cell Rep | 2024 | 38955182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57142/papers?page=5